© 2021 All rights reserved, FreshLeaf Analytics
FreshLeaf’s industry reports provide detailed and up-to-date information on medical cannabis in Australia. We track product availability, price movements, new market entrants, doctor behaviour, patient preferences, regulatory changes and more. The reports are free to download and showcase our capability. Please contact us if you would like to discuss custom analysis to address your specific business requirements.
The H1 2021 report is FreshLeaf Analytics’ sixth market report on patients, products and pricing in the Australian market.
Our Q3 2020 report is FreshLeaf Analytics’ fifth market report on patients, products and pricing in the Australian market.
Our Q1 2020 report includes our first ever historical price and patient dose analysis combining data from our previous publications to show long-term market trends.
Our Q3 2019 report is the most comprehensive review of the marketplace to date, the product of two-and-a-half years constantly and cumulatively tracking data.
Our Q1 2019 report gives insight for the first time into new metrics around product floor prices, revenue forecasts and market size.
Our analysis has revealed that over the past 12 months, there has been a significant increase in the number, and variety of legal products on offer to Australian patients.
© 2021 All rights reserved, FreshLeaf Analytics